QIAGEN NV
QGENF
QGENF was delisted on the 14th of February, 2005.
2 hedge funds and large institutions have $1K invested in QIAGEN NV in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $47M → $1K (-$47M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFM
Premier Fund Managers
Guildford,
United Kingdom
|
-$47M |
QGENF Hedge Fund Activity: Q4 2020 in Review
2 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in QIAGEN NV (QGENF) for Q4 2020, worth a combined $1K — down 100% from $47M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of QGENF and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Premier Fund Managers, exiting entirely with an estimated $47M sold.
- 2 institutional investors held QIAGEN NV (QGENF) as of Q4 2020, down from 3 in Q3 2020.
- Funds reported $1K of QIAGEN NV stock for Q4 2020, down 100% quarter-over-quarter.
- 0 funds opened new QIAGEN NV positions in Q4 2020 and 1 closed out, a net change of -1 holder.
- The largest QIAGEN NV seller in Q4 2020 was Premier Fund Managers, an estimated $47M sold.
Based on aggregated 13F filings for Q4 2020.